Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
Clinical and Molecular Hepatology. 2020;26(2):185-186 
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
BMC Gastroenterology. 2010;10(1):
Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis
Journal of Gastroenterology and Hepatology. 2015;30(7):1190-1196
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis
Journal of Hepatology. 2007;47(4):571-579
P1089 : Cellular senescence and lipopolysaccharide/toll-like receptor 4 signaling in alcoholic steatohepatitis
Journal of Hepatology. 2015;62:S758
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
Journal of Gastroenterology and Hepatology. 2013;28:38-42
Clinical Significance of Toll-Like Receptor and Toll-Like Receptor Blocker
Urogenital Tract Infection. 2016;11(1):1
Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis
Alcohol. 2013;47(6):459-465
Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease
Scientific Reports. 2016;6(1):
Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study
Acta Histochemica. 2018;120(3):242-254